Release Date: 28/04/11 11:00 Summary: Notice of General Meeting of Shareholders Price Sensitive: No Download Document 583.28KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%